Dyne Therapeutics, Inc.
DYN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$108,041 | -$110,858 | -$115,361 | -$89,542 |
| Dep. & Amort. | $500 | $503 | $502 | $1,020 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $10,523 | $13,020 | $0 |
| Change in WC | $5,868 | $5,641 | -$3,602 | -$5,085 |
| Other Non-Cash | $10,894 | -$512 | -$452 | $9,272 |
| Operating Cash Flow | -$90,779 | -$94,703 | -$105,893 | -$84,335 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$19,185 | -$60 | -$981 | -$1,075 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$46,920 | -$40,933 | -$65,970 | -$52,714 |
| Inv. Sales/Matur. | $28,140 | $47,753 | $68,409 | $37,779 |
| Other Inv. Act. | $0 | $14 | $0 | $0 |
| Investing Cash Flow | -$37,965 | $6,774 | $1,458 | -$16,010 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$549 | $98,802 | $0 | $0 |
| Stock Issued | $217,876 | $1,972 | $140,653 | $3,636 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $588 | $0 |
| Financing Cash Flow | $217,327 | $100,774 | $141,241 | $3,636 |
| Forex Effect | -$13 | $0 | $0 | -$5 |
| Net Chg. in Cash | $88,570 | $12,845 | $36,806 | -$96,714 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $485,040 | $474,197 | $437,391 | $532,163 |
| End Cash | $573,610 | $487,042 | $474,197 | $435,449 |
| Free Cash Flow | -$109,964 | -$94,763 | -$106,874 | -$85,410 |